NFKB1 and breast carcinoma: Combining indicators of inflammation such as evidence of local breast adipose tissue inflammation (as indicated by CLS-B and NF-κB binding activity in the breast tissue) and systemic inflammation (as indicated by elevated cytokines and chemokines in the blood) may be another way to identify women at particularly high risk of poor breast cancer outcomes.